Patel Rajendrabhai

Production Executive at JRS Pharma LP - Patterson, NY, US

Patel Rajendrabhai's Contact Details
HQ
845-878-3414
Location
Ahmedabad,Gujarat,India
Company
JRS Pharma LP
Patel Rajendrabhai's Company Details
JRS Pharma LP logo, JRS Pharma LP contact details

JRS Pharma LP

Patterson, NY, US • 1000 - 4999 Employees
Major Drugs

JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of solutions for the global health science industry. Our excipients portfolio includes: high functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, carriers, and coatings. In addition to our wide range of excipients, we offer excellent technical support to address the needs and formulation challenges of our customers. We are dedicated to serving the health science industry worldwide. Founded in 1878, the JRS Group has over 135 years of experience. Our 7 R&D centers, 31 production sites, and 25 sales offices, as well as our technical support team and award-winning customer service team offer our customers the most cost-effective and fast time-to-market solutions.

Broadest array of excipients in the marketplace Most complete portfolio of high functionality excipients Technical expertise for the global pharmaceutical and nutritional industries Major Drugs Pharmaceutical Preparations Pharmaceuticals
Details about JRS Pharma LP
Frequently Asked Questions about Patel Rajendrabhai
Patel Rajendrabhai currently works for JRS PHARMA.
Patel Rajendrabhai's role at JRS PHARMA is Production Executive.
Patel Rajendrabhai's email address is ***@jrspharma.com. To view Patel Rajendrabhai's full email address, please signup to ConnectPlex.
Patel Rajendrabhai works in the Pharmaceuticals industry.
Patel Rajendrabhai's colleagues at JRS Pharma LP are Angela Lima, Keith Villanueva, Patel Pravin, Valdomero Melo, Valentin Martinez, Steve Gonzalez, German Salgado and others.
Patel Rajendrabhai's phone number is 845-878-3414
See more information about Patel Rajendrabhai